JP2008507538A - 置換アミドβセクレターゼインヒビター - Google Patents
置換アミドβセクレターゼインヒビター Download PDFInfo
- Publication number
- JP2008507538A JP2008507538A JP2007522711A JP2007522711A JP2008507538A JP 2008507538 A JP2008507538 A JP 2008507538A JP 2007522711 A JP2007522711 A JP 2007522711A JP 2007522711 A JP2007522711 A JP 2007522711A JP 2008507538 A JP2008507538 A JP 2008507538A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- substituted
- aryl
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CCCc1cc(C[C@@](CC*(*)CC*(Cc2ccccc2)C=O)*I)ccc1 Chemical compound CCCc1cc(C[C@@](CC*(*)CC*(Cc2ccccc2)C=O)*I)ccc1 0.000 description 3
- WRXOZRLZDJAYDR-UHFFFAOYSA-N Cc1cc(S)ccc1 Chemical compound Cc1cc(S)ccc1 WRXOZRLZDJAYDR-UHFFFAOYSA-N 0.000 description 2
- NPRAEQKJCWHOCK-UHFFFAOYSA-N C1CC2OCCOC2CC1 Chemical compound C1CC2OCCOC2CC1 NPRAEQKJCWHOCK-UHFFFAOYSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N C1Oc(cccc2)c2O1 Chemical compound C1Oc(cccc2)c2O1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- GMVSBVSVUQDHNN-VWLOTQADSA-N C=CCOc1cc(C[C@@H](CO)N(Cc2ccccc2)Cc2ccccc2)cc(F)c1 Chemical compound C=CCOc1cc(C[C@@H](CO)N(Cc2ccccc2)Cc2ccccc2)cc(F)c1 GMVSBVSVUQDHNN-VWLOTQADSA-N 0.000 description 1
- SDGUHJAZKCARDF-UHFFFAOYSA-N C=CCOc1cc(F)cc(Br)c1 Chemical compound C=CCOc1cc(F)cc(Br)c1 SDGUHJAZKCARDF-UHFFFAOYSA-N 0.000 description 1
- DRXILRPKGACBCH-UHFFFAOYSA-N C=[Br]c1cc(F)cc(Cc2ccccc2)c1 Chemical compound C=[Br]c1cc(F)cc(Cc2ccccc2)c1 DRXILRPKGACBCH-UHFFFAOYSA-N 0.000 description 1
- ISUYMHMEEXPVGK-YTMVLYRLSA-N CC(C)(C)OC(N(CC1)CCN1c1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N)c1)=O Chemical compound CC(C)(C)OC(N(CC1)CCN1c1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N)c1)=O ISUYMHMEEXPVGK-YTMVLYRLSA-N 0.000 description 1
- OTBBDCMPKZSOMD-UHFFFAOYSA-N CC(C)(C)OC(N(CCN1Cc2ccccc2)CC1=O)=O Chemical compound CC(C)(C)OC(N(CCN1Cc2ccccc2)CC1=O)=O OTBBDCMPKZSOMD-UHFFFAOYSA-N 0.000 description 1
- BSUARKFCSLHTOC-QARUCVQPSA-N CC(C)(C)OC(N(CCN1Cc2ccccc2)[C@@H](C[C@H](Cc2cc(F)cc(OCC=C)c2)N(Cc2ccccc2)Cc2ccccc2)C1=O)=O Chemical compound CC(C)(C)OC(N(CCN1Cc2ccccc2)[C@@H](C[C@H](Cc2cc(F)cc(OCC=C)c2)N(Cc2ccccc2)Cc2ccccc2)C1=O)=O BSUARKFCSLHTOC-QARUCVQPSA-N 0.000 description 1
- MTUYSHOIUGFHHY-UNMCSNQZSA-N CC(C)(C)OC(N(CCN1Cc2ccccc2)[C@@H](C[C@H](Cc2cc(O)cc(F)c2)N)C1=O)=O Chemical compound CC(C)(C)OC(N(CCN1Cc2ccccc2)[C@@H](C[C@H](Cc2cc(O)cc(F)c2)N)C1=O)=O MTUYSHOIUGFHHY-UNMCSNQZSA-N 0.000 description 1
- UVTMJXOPXKLMLF-HSZRJFAPSA-N CC(C)(C)OC(N(CC[C@H](Cc1cc(O)cc(F)c1)NC)CCN(C)Cc1ccccc1)=O Chemical compound CC(C)(C)OC(N(CC[C@H](Cc1cc(O)cc(F)c1)NC)CCN(C)Cc1ccccc1)=O UVTMJXOPXKLMLF-HSZRJFAPSA-N 0.000 description 1
- BOULMKGNQBTPMU-AHWVRZQESA-N CC(C)CCOc1cc(F)cc(C[C@@H](C[C@@H]2NCCN(Cc3ccccc3)C2=O)NC(C)=O)c1 Chemical compound CC(C)CCOc1cc(F)cc(C[C@@H](C[C@@H]2NCCN(Cc3ccccc3)C2=O)NC(C)=O)c1 BOULMKGNQBTPMU-AHWVRZQESA-N 0.000 description 1
- NJVJZVPLAVBXPS-MUUNZHRXSA-N CC(N[C@H](CCNCCN(Cc1ccccc1)C=O)Cc1cc(OCc2ccccc2)cc(F)c1)=O Chemical compound CC(N[C@H](CCNCCN(Cc1ccccc1)C=O)Cc1cc(OCc2ccccc2)cc(F)c1)=O NJVJZVPLAVBXPS-MUUNZHRXSA-N 0.000 description 1
- JWWLQTYYINAHMF-XCZPVHLTSA-N CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc(cc2)ccc2Cl)cc(F)c1)=O Chemical compound CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc(cc2)ccc2Cl)cc(F)c1)=O JWWLQTYYINAHMF-XCZPVHLTSA-N 0.000 description 1
- CTDPUDMNFKYLIO-WNJJXGMVSA-N CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2cc(OC)ccc2)cc(F)c1)=O Chemical compound CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2cc(OC)ccc2)cc(F)c1)=O CTDPUDMNFKYLIO-WNJJXGMVSA-N 0.000 description 1
- CJLCMTOARKAILV-DHLKQENFSA-N CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2ccc(C(F)(F)F)[o]2)cc(F)c1)=O Chemical compound CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2ccc(C(F)(F)F)[o]2)cc(F)c1)=O CJLCMTOARKAILV-DHLKQENFSA-N 0.000 description 1
- ZNNRNQRZOJUYQY-BDYUSTAISA-N CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2ccncc2)cc(F)c1)=O Chemical compound CC(N[C@H](C[C@@H]1NCCN(Cc2ccccc2)C1=O)Cc1cc(OCc2ccncc2)cc(F)c1)=O ZNNRNQRZOJUYQY-BDYUSTAISA-N 0.000 description 1
- LPMNPEVCDMMTKI-PJLXGWBQSA-N CC/C=C/COc1cc(F)cc(C[C@@H](C[C@@H](CN(Cc2ccccc2)CC2)N2C(OC(C)(C)C)=O)NC(C)=O)c1 Chemical compound CC/C=C/COc1cc(F)cc(C[C@@H](C[C@@H](CN(Cc2ccccc2)CC2)N2C(OC(C)(C)C)=O)NC(C)=O)c1 LPMNPEVCDMMTKI-PJLXGWBQSA-N 0.000 description 1
- MEDCXLXGWKVOGM-SMIXSIFNSA-N CC1C=CC=C(CN(CCN([C@H]2C[C@H](Cc3cc(N(CC4)CCN4C(OC(C)(C)C)=O)ccc3)N(Cc3ccccc3)Cc3ccccc3)C(OC(C)(C)C)=O)C2=O)C1 Chemical compound CC1C=CC=C(CN(CCN([C@H]2C[C@H](Cc3cc(N(CC4)CCN4C(OC(C)(C)C)=O)ccc3)N(Cc3ccccc3)Cc3ccccc3)C(OC(C)(C)C)=O)C2=O)C1 MEDCXLXGWKVOGM-SMIXSIFNSA-N 0.000 description 1
- HXSCURIRQIHACD-ALCCZGGFSA-N CCC(CC)=C/C=C\N Chemical compound CCC(CC)=C/C=C\N HXSCURIRQIHACD-ALCCZGGFSA-N 0.000 description 1
- CCILAFJQFQFGHX-VXKWHMMOSA-N CCCCCOc1cc(C[C@@H](C[C@@H](CNCC2)N2C(OC(C)(C)C)=O)NC(C)=O)cc(F)c1 Chemical compound CCCCCOc1cc(C[C@@H](C[C@@H](CNCC2)N2C(OC(C)(C)C)=O)NC(C)=O)cc(F)c1 CCILAFJQFQFGHX-VXKWHMMOSA-N 0.000 description 1
- QBNRGSJGJXTJTF-YDAXCOIMSA-N CCCc1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N(Cc2ccccc2)Cc2ccccc2)c1 Chemical compound CCCc1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N(Cc2ccccc2)Cc2ccccc2)c1 QBNRGSJGJXTJTF-YDAXCOIMSA-N 0.000 description 1
- YREZTNCZNWRAHR-DQEYMECFSA-N CCCc1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N)c1 Chemical compound CCCc1cccc(C[C@@H](C[C@@H](C(N(Cc2ccccc2)CC2)=O)N2C(OC(C)(C)C)=O)N)c1 YREZTNCZNWRAHR-DQEYMECFSA-N 0.000 description 1
- ULVNWAWZNVCNRB-UHFFFAOYSA-N CCc1ccc(C(F)(F)F)[o]1 Chemical compound CCc1ccc(C(F)(F)F)[o]1 ULVNWAWZNVCNRB-UHFFFAOYSA-N 0.000 description 1
- MFEIKQPHQINPRI-UHFFFAOYSA-N CCc1cccnc1 Chemical compound CCc1cccnc1 MFEIKQPHQINPRI-UHFFFAOYSA-N 0.000 description 1
- NRGGMCIBEHEAIL-UHFFFAOYSA-N CCc1ncccc1 Chemical compound CCc1ncccc1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- FCSGCOXBPQGOIC-UHFFFAOYSA-N OC(c1ccccc1)c1cc(Br)cc(F)c1 Chemical compound OC(c1ccccc1)c1cc(Br)cc(F)c1 FCSGCOXBPQGOIC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59010204P | 2004-07-22 | 2004-07-22 | |
| PCT/US2005/025780 WO2006014762A1 (en) | 2004-07-22 | 2005-07-20 | Substituted amide beta secretase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008507538A true JP2008507538A (ja) | 2008-03-13 |
| JP2008507538A5 JP2008507538A5 (cg-RX-API-DMAC7.html) | 2008-08-14 |
Family
ID=35431616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007522711A Pending JP2008507538A (ja) | 2004-07-22 | 2005-07-20 | 置換アミドβセクレターゼインヒビター |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7803802B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1781625B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008507538A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101014577A (cg-RX-API-DMAC7.html) |
| AR (1) | AR049726A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE491693T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2574218A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005025363D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2355733T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007000760A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200621249A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006014762A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| ATE482214T1 (de) | 2005-06-14 | 2010-10-15 | Schering Corp | Aspartylproteasehemmer |
| WO2006138264A2 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
| CA2653650A1 (en) | 2006-06-12 | 2007-12-21 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| MX2009006228A (es) | 2006-12-12 | 2009-06-22 | Schering Corp | Inhibidores de aspartil proteasa. |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| CN101848897A (zh) | 2007-09-06 | 2010-09-29 | 先灵公司 | γ分泌酶调节剂 |
| US8487099B2 (en) | 2007-11-05 | 2013-07-16 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
| WO2009076352A1 (en) | 2007-12-11 | 2009-06-18 | Schering Corporation | Gamma secretase modulators |
| AU2009239536C1 (en) | 2008-04-22 | 2012-12-13 | Merck Sharp & Dohme Corp. | Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| JP5503663B2 (ja) | 2008-11-13 | 2014-05-28 | メルク・シャープ・アンド・ドーム・コーポレーション | ガンマセクレターゼモジュレータ |
| AU2009330233A1 (en) | 2008-12-22 | 2011-07-07 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
| EP2379566A2 (en) | 2008-12-22 | 2011-10-26 | Schering Corporation | Gamma secretase modulators |
| WO2010147969A2 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | Gamma secretase modulators |
| US20120245158A1 (en) | 2009-06-16 | 2012-09-27 | Xianhai Huang | Gamma secretase modulators |
| EP2443118A1 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| WO2011044185A2 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
| WO2011044187A1 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| WO2011044184A1 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| RU2014111055A (ru) | 2011-08-22 | 2015-09-27 | Мерк Шарп И Доум Корп. | 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение |
| US20130060021A1 (en) * | 2011-09-07 | 2013-03-07 | Satori Pharmaceuticals, Inc. | Compounds useful for treating neurodegenerative disorders |
| ES2745539T3 (es) | 2012-03-19 | 2020-03-02 | Buck Inst Res Aging | Inhibidores de BACE específicos de APP (ASBI) y uso de los mismos |
| EP2908825B1 (en) | 2012-10-17 | 2018-04-18 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| WO2014062553A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP3653609B1 (en) | 2013-02-12 | 2024-04-03 | Buck Institute for Research on Aging | Hydantoins that modulate bace-mediated app processing |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035613A2 (en) * | 2001-10-22 | 2003-05-01 | Enanta Pharmaceuticals, Inc. | Nitrogen heterocycle inhibitors of aspartyl protease |
| WO2004043916A1 (en) * | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| JP2007533741A (ja) * | 2004-04-22 | 2007-11-22 | イーライ リリー アンド カンパニー | Bace阻害剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI902006A7 (fi) * | 1987-10-21 | 1990-04-20 | Upjohn Co | Menetelmä renniini-inhibiittoreiden valmistamiseksi, jotka sisältävät 1-amino-2-hydroksi-2-heterosyklisen etyylitähteen |
| HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| CN1348442A (zh) | 1999-02-26 | 2002-05-08 | 默克公司 | 新的磺胺化合物及其应用 |
| DE19934145C2 (de) * | 1999-07-26 | 2001-05-23 | Deutsche Telekom Mobil | Verfahren zur Herstellung von Kommunikationsverbindungen zu einer, einem Fahrzeug oder sonstigen mobilen oder ortsfesten Einrichtung zugeordneten, vorzugsweise mobilen Kommunikationsendeinrichtung |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| CA2410680A1 (en) | 2000-06-30 | 2002-01-10 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
| JP2004534017A (ja) | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Baceのインヒビター |
| US7122675B2 (en) | 2001-08-03 | 2006-10-17 | Schering Corporation | Gamma secretase inhibitors |
| MXPA04001014A (es) | 2001-08-03 | 2004-05-27 | Schering Corp | Novedosos inhibidores de la gama secretasa. |
| JP3711131B2 (ja) | 2001-08-21 | 2005-10-26 | メルク シャープ エンド ドーム リミテッド | 新規のシクロヘキシルスルホン |
| TW200302717A (en) | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
| US6974829B2 (en) | 2002-05-07 | 2005-12-13 | Elan Pharmaceuticals, Inc. | Succinoyl aminopyrazoles and related compounds |
| AU2002311553A1 (en) | 2002-06-26 | 2004-01-19 | Nokia Corporation | Method and network element for optimisation of radio resource utilisation in a radio access network |
| WO2007058862A2 (en) * | 2005-11-16 | 2007-05-24 | Merck & Co., Inc. | Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
-
2005
- 2005-07-20 JP JP2007522711A patent/JP2008507538A/ja active Pending
- 2005-07-20 WO PCT/US2005/025780 patent/WO2006014762A1/en not_active Ceased
- 2005-07-20 AT AT05773473T patent/ATE491693T1/de not_active IP Right Cessation
- 2005-07-20 CN CNA2005800300344A patent/CN101014577A/zh active Pending
- 2005-07-20 ES ES05773473T patent/ES2355733T3/es not_active Expired - Lifetime
- 2005-07-20 MX MX2007000760A patent/MX2007000760A/es active IP Right Grant
- 2005-07-20 US US11/185,419 patent/US7803802B2/en active Active
- 2005-07-20 DE DE602005025363T patent/DE602005025363D1/de not_active Expired - Lifetime
- 2005-07-20 EP EP05773473A patent/EP1781625B1/en not_active Expired - Lifetime
- 2005-07-20 AR ARP050103000A patent/AR049726A1/es not_active Application Discontinuation
- 2005-07-20 CA CA002574218A patent/CA2574218A1/en not_active Abandoned
- 2005-07-21 TW TW094124686A patent/TW200621249A/zh unknown
-
2010
- 2010-08-23 US US12/861,347 patent/US8367712B2/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035613A2 (en) * | 2001-10-22 | 2003-05-01 | Enanta Pharmaceuticals, Inc. | Nitrogen heterocycle inhibitors of aspartyl protease |
| WO2004043916A1 (en) * | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| JP2007533741A (ja) * | 2004-04-22 | 2007-11-22 | イーライ リリー アンド カンパニー | Bace阻害剤 |
| JP2007533740A (ja) * | 2004-04-22 | 2007-11-22 | イーライ リリー アンド カンパニー | Bace阻害剤としてのアミド |
Also Published As
| Publication number | Publication date |
|---|---|
| US8367712B2 (en) | 2013-02-05 |
| TW200621249A (en) | 2006-07-01 |
| AR049726A1 (es) | 2006-08-30 |
| US7803802B2 (en) | 2010-09-28 |
| MX2007000760A (es) | 2007-04-09 |
| CN101014577A (zh) | 2007-08-08 |
| CA2574218A1 (en) | 2006-02-09 |
| ES2355733T3 (es) | 2011-03-30 |
| EP1781625A1 (en) | 2007-05-09 |
| US20060040994A1 (en) | 2006-02-23 |
| EP1781625B1 (en) | 2010-12-15 |
| US20110003825A1 (en) | 2011-01-06 |
| DE602005025363D1 (de) | 2011-01-27 |
| WO2006014762A1 (en) | 2006-02-09 |
| ATE491693T1 (de) | 2011-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8367712B2 (en) | Substituted amide beta secretase inhibitors | |
| EP1781644B1 (en) | Macrocyclic beta-secretase inhibitors | |
| JP4448134B2 (ja) | ベンズアミド置換基を有する環状アミンbase−1阻害剤 | |
| JP4472700B2 (ja) | 複素環置換基を有する環状アミンbase−1阻害剤 | |
| JP5020638B2 (ja) | 複素環式アスパルチルプロテアーゼインヒビター | |
| JP2007513973A5 (cg-RX-API-DMAC7.html) | ||
| JP2008543841A (ja) | 大環状複素環式アスパルチルプロテアーゼインヒビター | |
| JP2009539983A (ja) | 複素環式アスパルチルプロテアーゼ阻害薬 | |
| JP2008543844A (ja) | アスパルチルプロテアーゼ阻害剤 | |
| JP2011518224A (ja) | Bace−1阻害剤としてのチオフェニル置換2−イミノ−3−メチルピロロピリミジノン化合物、組成物、およびそれらの使用 | |
| JP2010512389A (ja) | アスパルチルプロテアーゼ阻害剤 | |
| JP2010512390A (ja) | 三環式系を含むアスパルチルプロテアーゼ阻害剤 | |
| JP2009513656A (ja) | 複素環式アスパルチルプロテアーゼインヒビター | |
| JP2008546696A (ja) | 複素環式アスパルチルプロテアーゼ阻害剤、その調製及び使用 | |
| JP2008543846A (ja) | プロテアーゼ阻害剤として化合物の調製およびその使用 | |
| WO2011044185A2 (en) | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use | |
| HK1102328B (en) | Macrocyclic beta-secretase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080620 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080620 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110418 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110420 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111027 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120316 |